Hangzhou Rongda Pharm & Chem Co., Ltd
Manufacturer
Business Nature
Manufacturer
No. Employees
Above 1000 People
Year Established
2014
Annual Turnover
More than 6 Million US Dollar
Country/Region
Hangzhou, China
Main Products
Pharmaceutical APIs
Legal Status
Third Party
Payment Terms
Bank wire (T/T), Doc Against Payment (D/P), MoneyGram, Western Union (WU)
About Hangzhou Rongda Pharm & Chem Co., Ltd
Connect with Hangzhou Rongda Pharm & Chem Co., Ltd to go through the services of the best Manufacturer of Medical & Healthcare and many more China Pharmaceutical APIs, Pharmaceutical intermediates, Pharmaceutical raw materials, Ibandronate Sodium Monohydrate, Anastrozole, Letrozole, Fulvestrant, Palonosetron HCl, Azasetron HCl, Sorafenib tosylate, Lapatinib ditosylate, Tamiflu-Oseltamivir, cardiovascular dru goods. The branch of Hangzhou Rongda Pharm & Chem Co., Ltd is located in Hangzhou Zhejiang China. Hangzhou Rongda Pharm & Chem Co., Ltd presently handling with a industrial unit in China. Hangzhou Rongda Pharm & Chem Co., Ltd Details Name: Jessie Shen
Address: Hangzhou Zhejiang
Country: China
Main Products: Pharmaceutical APIs, Pharmaceutical intermediates, Pharmaceutical raw materials, Ibandronate Sodium Monohydrate, Anastrozole, Letrozole, Fulvestrant, Palonosetron HCl, Azasetron HCl, Sorafenib tosylate, Lapatinib ditosylate, Tamiflu-Oseltamivir, cardiovascular dru
Year Established: 2014
Export Focus: Australia, Brazil, Canada, France, United Kingdom
Estimated Employees: Above 1000 People
Registered Capital: Below US$1 Million
Ownership Status: Corporation Limited Liability Company
Export Percentage: 71% - 80%
Factory Size: 10, 000-30, 000 square meters
Production Lines: 1
Research Team Size: Fewer than 5
Contract Services: Buyer Label Offered
Main Markets
Send Your Inquiry Direct To This Supplier
Frequently Asked Questions - FAQ's
Trending Suppliers
Oseltamivir phosphate, Oxazole-2-amine, Dess-martin per...
entecavir, posaconazole, Pemetrexed, Lapatinib, Aliskir...
oseltamivir, MARBOFLOXACIN, TILMICOSIN, CLORSULON, RACT...